The demand for the numerous drug is growing in the pharmaceutical industries which are used as raw material for the manufacturing of pharmaceutical products. The liquid drugs are packed in vail or glass tubes and transported to manufacturers. The drug delivery products and devices are manufactured with the high quality of material that confirms the protection of the drug during the storage and transportation. Drug delivery devices are specialized tools for the delivery of a drug through a specific route of administration. Such devices are used as part of medical treatments. In the drug delivery devices, the liquid drugs are stored in the pharmaceuticals vail so the external factors external factors should not affect the composition of the drugs during transit of products.
Access Full Report at @ https://www.databridgemarketresearch.com/jp/reports/global-pharmaceutical-vials-market
Data Bridge Market Research analyses that the Pharmaceutical Vials Market is expected to grow at a CAGR of 7.35% in the forecast period of 2022 to 2029 and is expected to reach USD 23934.78 million by 2029 from USD 13571.04 million in 2021.
Numerous Product Developments in Pharmaceutical Vials Are Expected to Drive the Market
Numerous product developments in the healthcare industry are creating new demand potential for pharmaceutical vials. For instance, in 2022, SGD Pharma had previously introduced the first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology. The introduction of 100 ml molded glass vials to the Sterinity platform is revolutionary because SGD Pharma is the only international manufacturer of molded glass to provide this scale of solution in the RTU sector. The primary goal of medical professionals is to make sure that patients receive the correct dosage of medications, which has contributed to the rise in the popularity of pharmaceutical vials. The demand for novel treatments for chronic illnesses in hospitalized patients has also benefited producers in the pharmaceutical and biotechnology industries. The pharmaceutical vials market's growth rate is further boosted by favorable chances.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Material (Plastic, Glass, Others), Neck Type (Crimp Neck, Double Chamber, Screw Neck, Flip Cap, Others), Cap Size (13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM, Others), Market (Parenteral, Gastro, ENT, Others), Drug Type (Injectable, Non-Injectable), Capacity (1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML, Others), Application (Nasal, Oral, Others), Distribution Channel (Direct Sales, Medical Stores/Pharmacies, E-Commerce, Others), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development and Manufacturing Companies, Compound Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Schott AG (Germany), Nipro (Japan), Piramal Glass (India), Sisecam (Turkey), Owens-Illinois Inc. (U.S.), Gerresheimer AG (Germany), Bormioli Pharma S.p.A (Italy), Ardagh Group S.A. (Luxembourg), West Pharmaceutical Services Inc. (U.S.), STOELZLE GLASS GROUP (Austria), SGD Pharma (France), Shandong Qidu Pharmaceutical Co.,Ltd. (China), Corning Incorporated (U.S.), DWK Life Sciences (U.S.), Berry Global Inc (U.S.), Airnov (U.S.), Pacific Vial (U.S.), Stevanato Group (Italy), Adelphi Healthcare Packaging (U.K.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Segment Analysis:
Global pharmaceutical vials market is categorized into nine notable segments which are material, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market.
- On the basis of material, the global pharmaceutical vials market is segmented into plastic, glass and others. Glass segment is expected to dominate the market with 63.79% market share because of the non-leakage properties which are driving pharmaceutical vials market.
- On the basis of neck type, the global pharmaceutical vials market is segmented into crimp neck, double chamber, screw neck, flip cap and others.
Screw neck segment is expected to dominate the pharmaceutical vials market
Screw neck segment is expected to dominate the market with 35.69% market share because of growing application in gastro sector.
- On the basis of cap size, the global pharmaceutical vials market is segmented into 13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and others.
9MM segment is expected to dominate the pharmaceutical vials market
9MM segment is expected to dominate the market with 22.09% market share because the processing takes place at large scale due to requirement.
- On the basis of distribution channel, the global pharmaceutical vials market is segmented into direct sales, medical stores/pharmacies, e-commerce and others. Direct sales segment is expected to dominate the market with 78.01% market share because of the huge build relationships of the with the customers which boosts the demand of the pharmaceutical vials market.
- On the basis of capacity, the global pharmaceutical vials market is segmented into 1 M, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and others. 1 ML segment is expected to dominate the market with 17.60% market share because of high efficiency which boosts the demand of the pharmaceutical vials market.
- On the basis of drug type, the global pharmaceutical vials market is segmented into injectable and non-injectable. Injectable segment is expected to dominate the market with 57.83% market share because of properties which control the dosage consumption amount that maximizes its application.
- On the basis of application, the global pharmaceutical vials market is segmented into nasal, oral and others.
Oral segment is expected to dominate the pharmaceutical vials market
Oral segment is expected to dominate the market with 66.11% market share because of the huge amount of consumption in biopharmaceutical companies.
- On the basis of end-user, the global pharmaceutical vials market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy and others. Pharmaceutical companies segment is expected to dominate the market with 35.26% market share because of increasing formation of medicines to treat various diseases that is the reason which boosts the demand of the pharmaceutical vials market.
- On the basis of market, the global pharmaceutical vials market is segmented into parenteral, gastro, ENT and others. Parenteral segment is expected to dominate the market with 58.38% market share because of the increasing demand of the product that reduces patient concordance problems that is the reason which boosts the demand of the pharmaceutical vials market.
Major Players
Data Bridge Market Research recognizes the following companies as the major paint protection film market players in Pharmaceutical vials market are Schott AG (Germany), Nipro (Japan), Piramal Glass (India), Sisecam (Turkey), Owens-Illinois Inc. (U.S.), Gerresheimer AG (Germany), Bormioli Pharma S.p.A (Italy), Ardagh Group S.A. (Luxembourg), West Pharmaceutical Services Inc. (U.S.), STOELZLE GLASS GROUP (Austria), SGD Pharma (France), Shandong Qidu Pharmaceutical Co.,Ltd. (China), Corning Incorporated (U.S.), DWK Life Sciences (U.S.), Berry Global Inc (U.S.), Airnov (U.S.), Pacific Vial (U.S.), Stevanato Group (Italy), Adelphi Healthcare Packaging (U.K.)
Market Development
- In 2022, Bormioli Pharma announced a series of partnerships to improve the performance and sustainability of glass used in the pharmaceutical industry, enhance bottles' chemical resistance, and lower the carbon footprint associated with glass production.
- In 2021, The U.S. Food and Drug Administration (FDA) tentatively authorized Zydus Cadila Healthcare's request to market "pemetrexed" in single-dose injection vials of 500 mg, 100 mg, and 1000 mg.
- In 2022, SGD Pharma had previously announced the introduction of the first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology. The introduction of 100 ml molded glass vials to the Sterinity platform is revolutionary because SGD Pharma is the only international manufacturer of molded glass to provide this scale of solution in the RTU sector. The 100 ml vials are made of molded glass in clear and amber and are powered by the EZ-fill platform from The Stevanato Group. International firms can decrease the time it takes for their high-value parenteral medications to reach the market by using an RTU primary packaging solution suitable for large volumes.
Regional Analysis
Geographically, the countries covered in the paint protection film market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa
As per Data Bridge Market Research analysis:
North America is the dominant region in pharmaceutical vials market in the forecast period 2022 - 2029
North America is dominating due to the region's rising demand for pharmaceutical vials. The United States dominates the market for pharmaceutical vials in the North American region, because to increasing consumer awareness and company growth within this area.
Asia-Pacific is estimated to be the fastest-growing region in pharmaceutical vials market in the forecast period 2022 - 2029
Asia-Pacific is expected to grow the global pharmaceutical vials market due to the pharmaceutical industry which is using more and more pharmaceutical vials.
COVID-19 Impact Analysis
The exceptional COVID-19 pandemic has increased demand for parenteral medications, motivating industry participants to develop new sterile, secure pharmaceutical containers and maintain contamination-free conditions before organization. This will accelerate the market for pharmaceutical vials during a pandemic. On the other hand, the COVID-19 outbreak has severely reduced output and affected the supply chain in the manufacturing facility.
For more detailed information about the pharmaceutical vials market report, click here – https://www.databridgemarketresearch.com/jp/reports/global-pharmaceutical-vials-market
